Myricetin ameliorates experimental autoimmune myocarditis in mice by modulating immune response and inhibiting MCP-1 expression.

MLA

Nie, Na, et al. “Myricetin Ameliorates Experimental Autoimmune Myocarditis in Mice by Modulating Immune Response and Inhibiting MCP-1 Expression.” European Journal of Pharmacology, vol. 942, Mar. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejphar.2023.175549.

APA

Nie, N., Li, Z., Li, W., Huang, X., Jiang, Z., & Shen, Y. (2023). Myricetin ameliorates experimental autoimmune myocarditis in mice by modulating immune response and inhibiting MCP-1 expression. European Journal of Pharmacology, 942, N.PAG. https://doi.org/10.1016/j.ejphar.2023.175549

Chicago

Nie, Na, Zhuolun Li, Wenhuan Li, Xiao Huang, Zuli Jiang, and Yan Shen. 2023. “Myricetin Ameliorates Experimental Autoimmune Myocarditis in Mice by Modulating Immune Response and Inhibiting MCP-1 Expression.” European Journal of Pharmacology 942 (March): N.PAG. doi:10.1016/j.ejphar.2023.175549.